1. Home
  2. RNTX vs NSYS Comparison

RNTX vs NSYS Comparison

Compare RNTX & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$1.02

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

Logo Nortech Systems Incorporated

NSYS

Nortech Systems Incorporated

HOLD

Current Price

$16.55

Market Cap

41.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNTX
NSYS
Founded
2001
1981
Country
United States
United States
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
41.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
RNTX
NSYS
Price
$1.02
$16.55
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
841.5K
27.1K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.85
EPS
N/A
N/A
Revenue
N/A
$14,371,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.01
52 Week Low
$0.95
$6.50
52 Week High
$2.18
$18.01

Technical Indicators

Market Signals
Indicator
RNTX
NSYS
Relative Strength Index (RSI) 39.26 62.03
Support Level N/A $8.00
Resistance Level $1.33 N/A
Average True Range (ATR) 0.08 1.30
MACD 0.01 0.47
Stochastic Oscillator 24.94 78.20

Price Performance

Historical Comparison
RNTX
NSYS

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

Share on Social Networks: